Evidence map›Paper›PMID 40624965›Full record

ReviewAdvanced healthcare materials2025

Molecular Mechanisms of Extracellular Vesicle Biogenesis and Their Impact on the Design of Custom EVs.

Luís Carvalho Ferraz, Paulo Pereira, João Vasco Ferreira

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Kidney-heart crosstalk: the extracellular vesicles connection.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luís Carvalho FerraziNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon, 1169-056, Portugal.ORCID https://orcid.org/0009-0005-9749-9921
Paulo PereiraiNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon, 1169-056, Portugal.ORCID https://orcid.org/0000-0002-9908-2290
João Vasco FerreiraiNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon, 1169-056, Portugal.ORCID https://orcid.org/0000-0001-5897-7461

Funding

European Union, 1181 EVCA Twining Project 1182 Horizon GA n° 101079264Fundação para a Ciência e Tecnologia / Ministério da Educação, Ciência e InovaçãoiNOVA4Health - Programa de Medicina Translacional, by the Associated Laboratory LS4FUTURE LA/P/0087/2020Research Unit UID/04462TransNet Project 2022.08649.PTDC
6 · The paper itself

Abstract

Extracellular Vesicles (EVs) are nanosized lipid-bound particles that are pivotal for intercellular communication and actively participate in diverse physiological processes, including immune modulation, proteostasis, and tissue repair. EVs have emerged as promising therapeutic targets and biomarkers because of their significant roles in the pathogenesis of diseases, including cancer, neurodegeneration, and cardiovascular disorders. Despite extensive research on EVs as diagnostic tools and mediators of cellular signaling, the fundamental mechanisms underlying their biogenesis remain unclear. Consequently, this understanding of how the composition of EVs dynamically changes in response to physiological and pathological conditions is often limited, leading to lower diagnostic utility and slower advancements in clinical interventions and EVs engineering. This review explores the intricate mechanisms underlying EVs biogenesis and payload selection, emphasizing how these processes vary across EVs subclasses, thereby underpinning their functional versatility. The biogenetic pathways are highlighted from the ectocytosis-driven generation of microvesicles and apoptotic body (ApoBDs) formation via membrane blebbing to the formation of exosomes within the endosomal compartments and their regulated release via exocytosis.

Indexed as

Extracellular VesiclesAnimalsCell CommunicationExosomesHumansapoptotic bodiesexocytosisexosomesextracellular vesiclesmicrovesicles

Identifiers

PMID40624965
PMCPMC12417789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.